Trial Profile
A Randomized, Double-blinded, Single-dose, 3-arm Parallel, Comparative Study to Evaluate the Pharmacokinetics and Safety of BAT1406 A2 injection and BAT1406 B3 injection VS Adalimumab Injection in Healthy Chinese Male Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Adverse reactions; Pharmacokinetics
- 05 Sep 2018 New trial record